Exploratory study of fluorescence ICG sentinel lymph node biopsy using medical imaging projection system in patients with breast cancer

Exploratory study of fluorescence ICG sentinel lymph node biopsy using medical imaging projection system in patients with breast cancer - Exploratory study of fluorescence ICG sentinel lymph node biopsy using medical imaging projection system in patients with breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020768

Enrollment

Registered

2016-01-27

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Identification of sentinel lymph node using medical imaging projection system

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Histologically diagnosed female breast cancer patients 2) Clinical node negative (cN0) 3) Sentinel lymph node biopsy is planned for primary breast cancer 4) Age between 20 to 75 5) Informed consent

Exclusion criteria

Exclusion criteria: 1) After excisional biopsy for breast cancer or surgery for axillary lymph node 2) One who is allergic to ICG or iodine 3) Pregnant women or lactating women 4) Not suitable for this study judged by the investigator

Design outcomes

Primary

Measure	Time frame
Identification rate of sentinel lymph node using medical imaging projection system	—

Countries

Japan

Contacts

Public ContactMasahiro Takada

Kyoto University Hospital Breast Surgery

masahiro@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026